The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T-ACT (WJOG7112G): A randomized phase II study of weekly paclitaxel ± trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum.
 
Taito Esaki
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Akitaka Makiyama
No Relationships to Disclose
 
Tomomi Kashiwada
No Relationships to Disclose
 
Ayumu Hosokawa
Honoraria - Bayer; Chugai Pharma; Eisai; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Taiho Pharmaceutical (Inst)
 
Junji Kawada
No Relationships to Disclose
 
Toshikazu Moriwaki
Honoraria - Chugai Pharma; Merck; Novelpharm; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Boehringer Ingelheim (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Yoshiki Horie
No Relationships to Disclose
 
Hironaga Satake
No Relationships to Disclose
 
Katsunori Shinozaki
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline/Novartis; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma
 
Hiroyasu Ishida
No Relationships to Disclose
 
Hiroaki Tanioka
No Relationships to Disclose
 
Hiroshi Tsukuda
No Relationships to Disclose
 
Keita Uchino
No Relationships to Disclose
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)
 
Yasutaka Sukawa
No Relationships to Disclose
 
Takeharu Yamanaka
Honoraria - Boehringer Ingelheim; Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Shinichiro Nakamura
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Ichinosuke Hyodo
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly; Taiho Pharmaceutical; Yakult Honsha
 
Kei Muro
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha